Ledger.Open graph →
SEC Form D · Amendment · filed May 22, 2014

AV Therapeutics, Inc

Offering
$3.5M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Robert Pollock · New York, NYExecBanerjee K. Debabrata · New York, NYExecRaj K. Tiwari · New York, NYExec · DirectorAbraham Mittelman · New York, NYExec · DirectorJan K. Geliebter · New York, NYExecMorton Coleman · New York, NYExecJudith P. Jayson · Getzville, NYExec · DirectorSteven Heinz · Dublin, IrelandExecPeter Wagner · Menlo Park, CAExecCharles Silvey · San Francisco, CAExec · DirectorJohn Walecka · Menlo Park, CAExecDuncan Morton · Ketchum, IDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗